Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RX2Live is a private, active U.S. healthcare and wellness services company focused on helping physician practices, elder care facilities, and employers add value-based health programs and ancillary revenue streams. The company appears to operate a commercial services model rather than a traditional drug-development biotech platform, offering programs such as chronic care management, remote patient monitoring, behavioral health screening, lab services, DNA genetic blueprinting, and wellness-related offerings. RX2Live also appears to use a franchise or regional developer model to expand its services. Based on available public information, it is best characterized as a healthcare services and wellness company rather than a therapeutics developer, with no disclosed clinical drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RX2Live.